Corrigendum to: Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial.
Fichtenbaum CJ, Ribaudo HJ, Leon-Cruz J, Overton ET, Zanni MV, Malvestutto CD, Aberg JA, Kileel EM, Fitch KV, Van Schalkwyk M, Kumarasamy N, Martinez E, Santos BR, Joseph Y, Lo J, Siminski S, Melbourne K, Sponseller CA, Desvigne-Nickens P, Bloomfield GS, Currier JS, Hoffmann U, Douglas PS, Grinspoon SK.
Fichtenbaum CJ, et al. Among authors: douglas ps.
J Infect Dis. 2021 Feb 3;223(2):352. doi: 10.1093/infdis/jiaa594.
J Infect Dis. 2021.
PMID: 33068427
Free PMC article.
No abstract available.